<DOC>
	<DOC>NCT02183090</DOC>
	<brief_summary>Study to investigate the pharmacokinetics and tolerability of an intramuscular 15 mg meloxicam injection in comparison to the 15 mg oral tablet</brief_summary>
	<brief_title>Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Healthy subjects as determined by results of screening Written informed consent in accordance with Good Clinical Practice and local legislation Age ≥ 18 and ≤ 50 years Broca &gt; 20% and &lt; + 20% Any findings of the medical examination (including laboratory, blood pressure, pulse rate and electrocardiogram (ECG)) deviating from normal and of clinical relevance Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Surgery of the gastrointestinal tract ( except appendectomy) Diseases of the central nervous system (such as epilepsy) or psychiatric disorders Chronic or relevant acute infections Hypersensitivity to meloxicam and/or nonsteroidal antirheumatic agents Intake of drugs with a long halflife (&gt;24 hours) (≤ 1 month prior to administration or during the trial) Use of any drugs which might influence the results of the trial (≤ 10 days prior to administration or during the trial) Participation in another trial with an investigational drug (≤ 2 months prior to administration or during the trial) Smoker (&gt;= 10 cigarettes or &gt;= 3 cigars or &gt;= 3 pipes/day) Inability to refrain from smoking on study days Known alcohol abuse Known drug abuse Blood donation (≤ 1 month prior to administration) Excessive physical activities (≤ 5 days prior to administration) History of hemorrhagic diatheses History of gastrointestinal ulcer, perforation or bleeding History of bronchial asthma For female subjects: Pregnancy Positive pregnancy test No adequate contraception e.g. sterilization, IUD (intrauterine device), oral contraceptives Inability to maintain this adequate contraception during the whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>